Serplulimab

Hetronifly 10 MG/ML Concentrado Para Solucion Para Perfusion

100 mg concentrado para solución para perfusiónSpainMarketedAuthorised 22 Apr 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

HetroniflyEuropean UnionAuthorised

HetroniflyEuropean Union · Accord Healthcare S.L.U.Same brand
HetroniflyCroatiaSame brand
HetroniflyItaly · Concentrato per soluzione per infusione · Accord Healthcare, S.L.U.Same brand
HETRONIFLY 10 mg/ml concentraat voor oplossing voor infusie.Netherlands · Concentraat voor oplossing voor infusie · Accord Healthcare S.L.U.Same brand
ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10mlSingapore · 100mg/10ml · injection, solution, concentrate · Abbott Laboratories (Singapore ) Private LimitedSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Serplulimab

Hetronifly 10 MG/ML Concentrado Para Solucion Para Perfusion

100 mg concentrado para solución para perfusiónSpainMarketedAuthorised 22 Apr 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

HetroniflyEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

OlizuBrazil · Abbott Laboratórios do Brasil Ltda

Packs

Pack	Code	Status
HETRONIFLY 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml	767503

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Serplulimab
Strength: 100 mg
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 22 Apr 2025
Registration: 1241870001
Marketing authorisation holder: Accord Healthcare S.L.U.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/24/1870